TAKHZYRO™ (lanadelumab injection)

This site is based on the EU Summary of Product Characteristics, and is
intended for healthcare professionals outside of the US, UK, and Ireland.

  • Safety Information
  • EU Product Information
  • Safety Information
  • EU Product Information
  • HAE Overview
  • Efficacy
  • MoA
  • Dosing
  • QoL
  • Safety
  • CONTACT A TAKEDA REPRESENTATIVE

CONTACT A TAKEDA
REPRESENTATIVE

If you would like to receive further information on TAKHZYRO or receive a visit from a
local Takeda representative, please complete the form below.

First Name
Last Name
Email*
Specialty
Country*
By providing your information, you consent to receiving marketing and promotional communications and other information from Takeda. You hereby give consent to Takeda, its affiliates, and their agents and representatives to send communications and information to you via the contact information you have provided above. This consent will be in effect until such time as you opt out of communications from Takeda.
For more information on how Takeda processes your personal data and your rights related to this processing, please refer to our Privacy Notice.

*Required.

  • Site Map
  • Medical Information
  • Privacy Policy
  • Legal Notice
  • Takeda
Takeda logo

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of the SmPC for how to report adverse reactions.

This website is intended to provide information to healthcare professionals outside the United States, United Kingdom, and Ireland. This website has been developed by Takeda in accordance with industry and legal standards about TAKHZYRO. Takeda makes every reasonable effort to include accurate and current information, however the information provided on this website is not exhaustive.

Copyright © 2022 Takeda Pharmaceutical Company Limited. All rights reserved. TAKHZYRO is a registered trademark of Dyax Corp., now part of Takeda. Takeda and the Takeda Logo are trademarks of Takeda Pharmaceutical Company Limited.

C-APROM/INT/LANA/0005 May 2022

HEADS UP!

You are now leaving int.TAKHZYRO.com
By clicking “Continue” below, you will be taken to a website that may contain links or references to other websites to which our Privacy Policy may not apply. We encourage you to read the privacy policy of every website you visit. By clicking the “No thanks” button below, you will be taken to the page you were on previously.

The information on this website is intended for an international healthcare professional audience outside of the United States, United Kingdom, and Ireland only.